• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    45 Stocks Moving In Monday's Mid-Day Session

    1/10/22 12:14:44 PM ET
    $AACG
    $ABSI
    $ACY
    $APR
    Other Consumer Services
    Real Estate
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $AACG alert in real time by email

    Gainers

    • Bone Biologics Corporation (NASDAQ:BBLG) shares climbed 71.5% to $5.88.
    • Zynga Inc. (NASDAQ:ZNGA) gained 45.7% to $8.74 after the company announced it will be acquired by Take-Two Interactive Software in a cash and stock transaction valued at $9.86 per Zynga share, representing a total enterprise value of approximately $12.7 billion.
    • Apria, Inc. (NASDAQ:APR) shares climbed 25.1% to $37.17. Owens & Minor agreed to acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion.
    • Pluristem Therapeutics Inc. (NASDAQ:PSTI) gained 22.5% to $1.80. Pluristem Therapeutics and Tnuva Group have collaborated to develop, manufacture and commercialize cultured cell-based products for the food industry.
    • Capstar Special Purpose Acquisition Corp. (NYSE:CPSR) shares rose 19.7% to $11.65.
    • Molecular Partners AG (NASDAQ:MOLN) rose 19.3% to $19.66 after the company, and Novartis, reported topline data from the Phase 2 study for ensovibep, a DARPin antiviral therapeutic for COVID-19.
    • Tilray, Inc. (NASDAQ:TLRY) surged 18.4% to $7.60 after the company announced fiscal second-quarter 2022 financial results showing revenue increased year-over-year and the company reached profitability.
    • BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) gained 17.6% to $13.59 after the company announced preliminary, unaudited ORLADEYO revenue for Q4 and FY21 and provided new guidance for full year 2022 ORLADEYO net revenue and expected peak ORLADEYO sales.
    • Discovery, Inc. (NASDAQ:DISCB) surged 15.7% to $41.02. The company, along with AT&T, recently won a favorable ruling from the Internal Revenue Service for the planned merger between the company and AT&T's WarnerMedia entertainment business.
    • AeroCentury Corp. (NYSE:ACY) jumped 15% to $11.04. AeroCentury, last month, reported a 5-for-1 split.
    • Olink Holding AB (NASDAQ:OLK) surged 14.1% to $13.33. Olink said it sees Q4 sales of $43.2 million to $43.7 million and expects FY21 sales of $94.5 million to $95 million.
    • Lucira Health, Inc. (NASDAQ:LHDX) gained 13.7% to $8.15 after the company issued strong sales forecast for the fourth quarter.
    • Reliance Global Group, Inc. (NASDAQ:RELI) rose 11.2% to $6.78. Reliance Global Group, last month, announced pricing of $20.0 million private placement with institutional investors.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) gained 11% to $5.95.
    • Century Therapeutics, Inc. (NASDAQ:IPSC) surged 10.4% to $14.59. Century Therapeutics and Bristol Myers Squibb have announced a research collaboration and license agreement for up to four induced pluripotent stem cell (iPSC) programs for hematologic malignancies and solid tumors.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) gained 9.7% to $2.4701. McDade Products, LLC joined forces with G Medical Tests and Services to provide U.S. retailers with millions of COVID-19 at-home PCR test kits.
    • CareDx, Inc (NASDAQ:CDNA) shares rose 8.3% to $42.29 after the company issued strong sales forecast.

    Check out these big penny stock gainers and losers

    Losers

    • TDH Holdings, Inc. (NASDAQ:PETZ) shares dipped 67.4% to $1.3301. TDH Holdings, last month, reported H1 revenue of $130,000.
    • Rapid Micro Biosystems, Inc. (NASDAQ:RPID) fell 24.3% to $6.92. Rapid Micro Biosystems said it expects Q4 total revenue of between $4.7 and $5.2 million.
    • Marpai, Inc. (NASDAQ:MRAI) shares declined 22.1% to $2.7450.
    • Kidpik Corp. (NASDAQ:PIK) dropped 21.3% to $5.15. Kidpik, last month, posted a Q3 loss of $0.22 per share.
    • Amicus Therapeutics, Inc. (NASDAQ:FOLD) dipped 19.2% to $9.22. Amicus Therapeutics said it sees FY21 Galafold sales of $306 million.
    • Hour Loop, Inc. (NASDAQ:HOUR) fell 18% to $6.55. The company’s stock jumped around 100% on Friday after the company priced its IPO at $4 per share.
    • Bird Global, Inc. (NYSE:BRDS) dipped 18% to $4.7550.
    • Citi Trends, Inc. (NASDAQ:CTRN) shares declined 17% to $67.32. Citi Trends reported 2021 holiday sales results and updated long-term strategic plan.
    • Cyngn Inc. (NASDAQ:CYN) dropped 16.8% to $3.02. Cyngn said Global Logistics and Fulfillment LLC has engaged the company as its exclusive autonomous vehicle solutions provider.
    • Pixelworks, Inc. (NASDAQ:PXLW) fell 16.4% to $3.4350.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) fell 16% to $1.7486.
    • Elite Education Group International Limited (NASDAQ:EEIQ) dropped 16% to $2.4673.
    • Zhangmen Education Inc. (NYSE:ZME) declined 15.6% to $1.8150.
    • CinCor Pharma, Inc. (NASDAQ:CINC) dipped 15.6% to $13.49. The company, on Friday, priced its IPO at $16 per share.
    • Marin Software Incorporated (NASDAQ:MRIN) fell 15% to $3.85. Marin Software shares jumped 31% on Friday after the company announced an integration with Amazon Ads' demand-side platform.
    • PetVivo Holdings, Inc. (NASDAQ:PETV) dropped 15% to $2.55.
    • OneSmart International Education Group Limited (NYSE:ONE) fell 14.5% to $0.2481 after gaining more than 5% on Friday.
    • Take-Two Interactive Software, Inc. (NASDAQ:TTWO) dropped 14.4% to $140.85 after the company announced it will acquire all of the outstanding shares of Zynga in a cash and stock transaction valued at $9.861 per Zynga share, with a total enterprise value of approximately $12.7 billion.
    • GameStop Corp. (NYSE:GME) dropped 14% to $120.94 amid overall market weakness following a rise in yields as well as continued Fed tapering concerns for 2022.
    • Absci Corporation (NASDAQ:ABSI) shares fell 12.5% to $6.29. Absci shares gained 17% on Friday after the company announced a research collaboration with Merck.
    • Bill.com Holdings, Inc. (NYSE:BILL) declined 12% to $177.66 amid a rise in bond yields, which has weighed on growth stock valuations. Bill.com is expected to report Q2 financial results on February 3, 2022
    • ATA Creativity Global (NASDAQ:AACG) fell 11.6% to $2.3350 after jumping more than 33% on Friday.
    • Torrid Holdings Inc. (NYSE:CURV) fell 11.5% to $9.47 after the company lowered its Q4 revenue guidance.
    • Vigil Neuroscience, Inc. (NASDAQ:VIGL) dipped 11.1% to $11.25. The company, on Friday, priced its IPO at $14 per share.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) fell 9.6% to $0.3367. FangDD, on Friday, received Nasdaq notice regarding minimum bid requirements.
    • Arcadia Biosciences, Inc. (NASDAQ:RKDA) shares fell 8.8% to $1.04 after climbing around 12% on Friday.
    • China HGS Real Estate Inc. (NASDAQ:HGSH) fell 8.6% to $3.1801 after jumping over 57% on Friday.
    • Lululemon Athletica Inc. (NASDAQ:LULU) dropped 5.6% to $335.30 after the company issued Q4 adjusted EPS and sales guidance below estimates.
    Get the next $AACG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AACG
    $ABSI
    $ACY
    $APR

    CompanyDatePrice TargetRatingAnalyst
    Tilray Brands Inc.
    $TLRY
    4/3/2026$10.00Neutral → Buy
    Roth Capital
    Tilray Brands Inc.
    $TLRY
    4/2/2026$10.00Neutral → Buy
    Roth Capital
    Immix Biopharma Inc.
    $IMMX
    3/25/2026$20.00Overweight
    Morgan Stanley
    lululemon athletica inc.
    $LULU
    3/18/2026$215.00 → $175.00Market Perform
    Telsey Advisory Group
    lululemon athletica inc.
    $LULU
    3/12/2026$303.00 → $250.00Buy
    BTIG Research
    Immix Biopharma Inc.
    $IMMX
    3/9/2026$23.00Mkt Outperform
    Citizens
    Century Therapeutics Inc.
    $IPSC
    2/25/2026Buy
    TD Cowen
    BioCryst Pharmaceuticals Inc.
    $BCRX
    2/18/2026$17.00Outperform
    Evercore ISI
    More analyst ratings

    $AACG
    $ABSI
    $ACY
    $APR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tilray upgraded by Roth Capital with a new price target

    Roth Capital upgraded Tilray from Neutral to Buy and set a new price target of $10.00

    4/3/26 10:44:58 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray upgraded by Roth Capital with a new price target

    Roth Capital upgraded Tilray from Neutral to Buy and set a new price target of $10.00

    4/2/26 7:55:13 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Morgan Stanley initiated coverage on Immix Biopharma with a new price target

    Morgan Stanley initiated coverage of Immix Biopharma with a rating of Overweight and set a new price target of $20.00

    3/25/26 8:30:25 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AACG
    $ABSI
    $ACY
    $APR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

    VANCOUVER, Wash. and NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will report business updates and financial and operating results for the first quarter 2026 after market close on Thursday, May 7, 2026. Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook. Live audio of the webcast will be available on the company's investor relations website at: investors.absci.com. The

    4/23/26 4:05:00 PM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today issued a statement applauding President Donald Trump's actions leading to rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act - a defining inflection point that represents a fundamental shift in U.S. drug policy, unlocking significant opportunities for medical cannabis clinical research, patient access, and industry standardization. The action represents the most consequential federal cannabis

    4/23/26 8:53:52 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Take-Two Interactive Software, Inc. to Report Fourth Quarter and Fiscal Year 2026 Results on Thursday, May 21, 2026

    Take-Two Interactive Software, Inc. (NASDAQ:TTWO) today announced that it plans to report financial results for its fourth quarter and fiscal year 2026, ended March 31, 2026, after the market close on Thursday, May 21, 2026. The Company plans to hold a conference call to discuss its results at 4:30 p.m. Eastern Time, which can be accessed by dialing (800) 715-9871 or (646) 307-1963 (conference ID: 9711440). A live, listen-only webcast and a replay of the call will be available at http://take2games.com/ir. About Take-Two Interactive Software Headquartered in New York City, Take-Two Interactive Software, Inc. is a leading developer, publisher, and marketer of interactive entertainment for

    4/23/26 8:00:00 AM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AACG
    $ABSI
    $ACY
    $APR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Innovation Officer Busch Andreas bought $229,000 worth of shares (100,000 units at $2.29), increasing direct ownership by 31% to 421,446 units (SEC Form 4)

    4 - Absci Corp (0001672688) (Issuer)

    3/16/26 4:17:22 PM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Large owner A.L. Sarroff Fund, Llc bought 1,250,000 shares (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    3/13/26 5:10:25 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Director Pangalos Menelas N bought $205,760 worth of shares (75,095 units at $2.74), increasing direct ownership by 66% to 189,055 units (SEC Form 4)

    4 - Absci Corp (0001672688) (Issuer)

    3/3/26 4:13:20 PM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $AACG
    $ABSI
    $ACY
    $APR
    SEC Filings

    View All

    $AACG
    $ABSI
    $ACY
    $APR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: CareDx Inc. filed SEC Form 8-K: Leadership Update

    8-K/A - CareDx, Inc. (0001217234) (Filer)

    4/23/26 4:12:41 PM ET
    $CDNA
    Medical Specialities
    Health Care

    SEC Form DEFA14A filed by BioCryst Pharmaceuticals Inc.

    DEFA14A - BIOCRYST PHARMACEUTICALS INC (0000882796) (Filer)

    4/23/26 4:10:57 PM ET
    $BCRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 8-K filed by Amicus Therapeutics Inc.

    8-K - AMICUS THERAPEUTICS, INC. (0001178879) (Filer)

    4/23/26 4:09:53 PM ET
    $FOLD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Seipel Kenneth Duane

    4 - Citi Trends Inc (0001318484) (Issuer)

    4/22/26 8:46:41 PM ET
    $CTRN
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    SEC Form 4 filed by Hopkinson David G.

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    4/22/26 5:30:45 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Kennedy Keith

    4 - CareDx, Inc. (0001217234) (Issuer)

    4/22/26 4:05:13 PM ET
    $CDNA
    Medical Specialities
    Health Care

    $AACG
    $ABSI
    $ACY
    $APR
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AACG
    $ABSI
    $ACY
    $APR
    Leadership Updates

    Live Leadership Updates

    View All

    lululemon Names Proven Brand Builder Heidi O'Neill as Chief Executive Officer

    O'Neill is a visionary, consumer-focused executive with more than three decades of experience leading brand strategy, product innovation, and operational execution on a global scale lululemon athletica inc. (NASDAQ:LULU) today announced that, following a comprehensive search process, the company's Board of Directors has unanimously approved the appointment of industry veteran Heidi O'Neill as the company's next Chief Executive Officer. Ms. O'Neill will start as CEO and join the Board effective September 8, 2026, and will be based in Vancouver. "Heidi is an inspiring leader and proven, consumer-driven brand strategist, with a rare ability to both imagine a new future for a brand and to c

    4/22/26 4:05:00 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    Nerdy Inc. Appoints Atul Bagga as Chief Financial Officer

    Nerdy Inc. (NYSE:NRDY), a leading platform for delivering live online learning, today announced the appointment of Atul Bagga as Chief Financial Officer, effective April 6, 2026. "Atul is a disciplined and strategic financial leader with deep experience scaling high-growth technology organizations and driving operational excellence," said Chuck Cohn, Founder, Chairman and Chief Executive Officer of Nerdy. "As we enter our next phase of growth from a position of strength, we remain focused on disciplined execution, continued margin expansion, and durable value creation. Atul's background will be instrumental in building on the strong foundation we have established." In this role, Mr. Bag

    4/6/26 9:00:00 AM ET
    $JLL
    $NRDY
    $ZNGA
    Real Estate
    Finance
    Other Consumer Services
    EDP Services

    BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer

    — Experienced R&D leader with a track record of advancing innovative therapies from early development to global approval —  RESEARCH TRIANGLE PARK, N.C., April 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced the appointment of Sandeep M. Menon, MD, PhD, as Chief Research and Development Officer. Building on the commercial success of ORLADEYO® and the recent acquisition of Astria Therapeutics and the navenibart program, BioCryst is entering a new phase of execution in its strategy to build value through development and commercialization of rare disease therapies. Dr. Menon joins BioCryst from Alnylam Pharmaceuticals, where he served as Chief Devel

    4/6/26 7:00:00 AM ET
    $BCRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AACG
    $ABSI
    $ACY
    $APR
    Financials

    Live finance-specific insights

    View All

    Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

    VANCOUVER, Wash. and NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will report business updates and financial and operating results for the first quarter 2026 after market close on Thursday, May 7, 2026. Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook. Live audio of the webcast will be available on the company's investor relations website at: investors.absci.com. The

    4/23/26 4:05:00 PM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Take-Two Interactive Software, Inc. to Report Fourth Quarter and Fiscal Year 2026 Results on Thursday, May 21, 2026

    Take-Two Interactive Software, Inc. (NASDAQ:TTWO) today announced that it plans to report financial results for its fourth quarter and fiscal year 2026, ended March 31, 2026, after the market close on Thursday, May 21, 2026. The Company plans to hold a conference call to discuss its results at 4:30 p.m. Eastern Time, which can be accessed by dialing (800) 715-9871 or (646) 307-1963 (conference ID: 9711440). A live, listen-only webcast and a replay of the call will be available at http://take2games.com/ir. About Take-Two Interactive Software Headquartered in New York City, Take-Two Interactive Software, Inc. is a leading developer, publisher, and marketer of interactive entertainment for

    4/23/26 8:00:00 AM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    BILL to Report Fiscal Third Quarter 2026 Financial Results

    BILL (NYSE:BILL), the intelligent finance platform trusted by half a million businesses to manage, move and maximize their money, announced today it will report financial results for its fiscal third quarter ended March 31, 2026 on Thursday, May 7, 2026 after the close of market. Management will conduct a conference call to discuss these results at 1:30 p.m. PT. The news release with financial results and a live webcast of the call will be accessible at https://investor.bill.com. Webcast replays can be accessed from BILL's Investor Relations website for approximately one year after the call. About BILL BILL (NYSE:BILL) is the intelligent finance platform trusted by nearly half a milli

    4/22/26 4:05:00 PM ET
    $BILL
    EDP Services
    Technology

    $AACG
    $ABSI
    $ACY
    $APR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary